Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EGR2 |
| Upstream (Parents) |
|---|
| (<<) TNFAIP6 → EGR2 |
| (<<) PLAU → EGR2 |
| (<<) LBH → EGR2 |
| (<<) PLAUR → EGR2 |
| (<<) FLNA → EGR2 |
| (<<) FILIP1L → EGR2 |
| (<<) LXN → EGR2 |
| Downstream (Children) |
|---|
| EGR2 → FUT9 (>>) |
| EGR2 → ADAMDEC1 (>>) |
| EGR2 → TRHDE (>>) |
| EGR2 → SLC2A5 (>>) |
| EGR2 → PCDHGC3 (>>) |
| EGR2 → KLF9 (>>) |
| EGR2 → GKN1 (>>) |
| EGR2 → CDH15 (>>) |
| EGR2 → LDLR (>>) |
| EGR2 → RIMS1 (>>) |
| EGR2 → DGCR14 (>>) |
| EGR2 → MMP19 (>>) |
| EGR2 → SLC16A10 (>>) |
| EGR2 → LOC26102 (>>) |
| EGR2 → EPB42 (>>) |
| EGR2 → TNFRSF13B (>>) |
| EGR2 → LXN (>>) |
